- Home
- BMRN vs QRVO Comparison
BMRN vs QRVO Comparison
Compare BMRN & QRVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BMRN
- QRVO
- Stock Information
- Founded
- BMRN 1996
- QRVO 1957
- Country
- BMRN United States
- QRVO United States
- Employees
- BMRN N/A
- QRVO N/A
- Industry
- BMRN Biotechnology: Pharmaceutical Preparations
- QRVO Semiconductors
- Sector
- BMRN Health Care
- QRVO Technology
- Exchange
- BMRN Nasdaq
- QRVO Nasdaq
- Market Cap
- BMRN 10.0B
- QRVO 8.5B
- IPO Year
- BMRN 1999
- QRVO 1997
- Fundamental
- Price
- BMRN $52.08
- QRVO $89.35
- Analyst Decision
- BMRN Buy
- QRVO Hold
- Analyst Count
- BMRN 19
- QRVO 14
- Target Price
- BMRN $90.89
- QRVO $97.54
- AVG Volume (30 Days)
- BMRN 2.8M
- QRVO 1.9M
- Earning Date
- BMRN 10-27-2025
- QRVO 11-03-2025
- Dividend Yield
- BMRN N/A
- QRVO N/A
- EPS Growth
- BMRN 59.53
- QRVO N/A
- EPS
- BMRN 2.68
- QRVO 2.30
- Revenue
- BMRN $3,094,001,000.00
- QRVO $3,663,072,000.00
- Revenue This Year
- BMRN $13.32
- QRVO $2.88
- Revenue Next Year
- BMRN $7.51
- QRVO $3.92
- P/E Ratio
- BMRN $19.59
- QRVO $38.12
- Revenue Growth
- BMRN 12.39
- QRVO N/A
- 52 Week Low
- BMRN $51.00
- QRVO $49.46
- 52 Week High
- BMRN $73.51
- QRVO $106.30
- Technical
- Relative Strength Index (RSI)
- BMRN 42.64
- QRVO 45.51
- Support Level
- BMRN $51.80
- QRVO $87.39
- Resistance Level
- BMRN $54.25
- QRVO $106.29
- Average True Range (ATR)
- BMRN 1.73
- QRVO 3.95
- MACD
- BMRN -0.03
- QRVO -0.38
- Stochastic Oscillator
- BMRN 18.34
- QRVO 10.37
About BMRN BioMarin Pharmaceutical Inc.
BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments designed to address complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria, hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development across skeletal conditions and enzyme therapies.
About QRVO Qorvo Inc.
Qorvo represents the combined entity of RF Micro Devices and TriQuint Semiconductor, which merged in January 2015. The company specializes in radio frequency filters, power amplifiers, and front-end modules used in many of the world's most advanced smartphones. Qorvo also has a suite of products sold into a variety of nonsmartphone end markets, such as wireless base stations, cable TV and networking equipment, and infrastructure and military applications.